Astrocyte Pharmaceuticals Presents NHP Stroke Study at International Stroke Conference

21Feb

Cambridge, MA, February 21, 2020 – Astrocyte Pharmaceuticals Inc. presented the results of a key preclinical efficacy study today at the International Stroke Conference in Los Angeles demonstrating...

Jeffrey L. Saver to Chair Astrocyte Pharmaceuticals’ Clinical Advisory Board

11Dec

Cambridge, MA, December 11, 2018 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, today announced that Jeffrey L. Saver, M.D., has joined the company’s Scientific Advisory...

Astrocyte Pharmaceuticals Completes $2.3M Pre-A Financing Round

6Jun

Cambridge, MA, June 6, 2018 – Astrocyte Pharmaceuticals Inc. announced today that it has completed a Pre-A financing round that raised over $2.3M. The company is advancing several small molecule neuroprotective...

Astrocyte Pharmaceuticals Awarded $3M NIH Small Business Grant to Advance TBI and Concussion Therapeutic

19Sep

Cambridge, MA, September 19, 2018 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that it has been awarded a $3 million Phase 2 Small Business Innovation Research...

Astrocyte Pharmaceuticals Awarded Alzheimer’s Disease Research Grant

18Sep

Cambridge, MA, September 18, 2018 – Astrocyte Pharmaceuticals, Inc., a privately held pharmaceutical company, announced today that it has been awarded $287k Phase 1 Small Business Technology Transfer...

Astrocyte Pharmaceuticals Completes $2.4M Seed Financing Round

17Jul

Cambridge, MA, July 17, 2017 – Astrocyte Pharmaceuticals Inc. announced today that it has completed its seed financing round raising over $2.4M. The company is developing novel small molecule drugs...

Astrocyte Pharmaceuticals Raises Over $1.3M in Seed Financing Round

24Mar

Cambridge, MA, March 24, 2017 – Astrocyte Pharmaceuticals Inc., a CNS therapeutics startup, announced today that it has raised approximately $1.36M in a seed financing round. The company is developing...

Former Army TBI Research Leader Col. Dallas Hack Joins Astrocyte Pharmaceuticals’ Scientific Advisory Board

19Dec

Cambridge, MA, December 19, 2016 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that Colonel (retired) Dallas C. Hack, MD, MPH has joined the company’s Scientific...

Leading Emergency Clinician David W. Wright Joins Astrocyte Pharmaceuticals’ Scientific Advisory Board

19Oct

Cambridge, MA, October 19, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that David W. Wright, M.D., has joined the company’s Scientific Advisory Board....

Astrocyte Pharmaceuticals Awarded NIH Small Business Grant to Advance TBI and Concussion Therapeutic

21Sep

Cambridge, MA, September 21, 2015 – Astrocyte Pharmaceuticals Inc., a privately held pharmaceutical company, announced today that it has been awarded a Phase 1 Small Business Technology Transfer (STTR)...

Category: Press Releases